EDGAR Filing Documents for 0001193125-18-213782

Form 8-K - Current report:

SEC Accession No. 0001193125-18-213782

Filing Date

2018-07-06

Accepted

2018-07-06 16:03:00

Documents

Period of Report

2018-06-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d656112d8k.htm	8-K	20645
2	EX-10.1	d656112dex101.htm	EX-10.1	207583
	Complete submission text file	0001193125-18-213782.txt		229590

Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462

Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577

Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)